James M. Young
Analyst · Ryan Davis
Thank you, Rich. Good morning, everyone. Before moving to Slide 8 and the details of our results, let me begin with some callouts. First, with Q2 and Q2 year-to-date revenue growth of 10% and 6%, respectively, we are on pace to achieve our full year guidance of 4% to 6% total revenue growth, especially with the tougher year-over-year revenue comparables behind us. Adjusted EPS grew 28% in Q2 and was down 3% for the first half, which was largely in line with our previous direction on how the distribution of earnings before interest and taxes, or EBIT, would fall between the first half and the second half of the year. So we reaffirm our full year guidance for adjusted diluted EPS of $2.42 to $2.52 representing 8% to 12% growth, again, with tough first half year-over-year EPS comparables behind us. Second, as Rich highlighted, we posted another quarter of strong sales, now up 112% for the first 6 months of the year. Similar to our commentary a quarter ago, we can expect some very modest revenue benefit in this fiscal year from new sales, but we maintain our revenue guidance. With respect to our recurring closed sales outlook, the strong first half numbers position us well to achieve our targeted range. We had meaningful contributions from large deals in the first half, and we have a good pipeline of large deals. That said, the timing of these large deals can be difficult to forecast precisely, so we maintain our range of $110 million to $150 million. Third, foreign exchange. Foreign exchange has been a drag of about 1 percentage point on revenue growth year-to-date, and we expect about a 1 percentage point drag on revenue growth for the full fiscal year. This is embedded in our revenue guidance. As a reminder, our FX exposure is largely from the Canadian dollar and the pound sterling. Our FX expense -- exposure to the Indian rupee has helped to mitigate the net impacts of FX a bit. That said, FX will still negatively impact earnings growth by about a point for the full year. Fourth, tax rate. We recorded a 32.8% rate for the second quarter, which translates into a 6-month year-to-date rate of 33.9%. This lower rate compared to our base rate of 35% is a function of a couple of discrete items, primarily the legislative reinstatement in December of the federal R&D tax credit for calendar year 2014. We now expect our tax rate for the full year to be about 34.5% or about 50 basis points lower than our previous guidance. And fifth, and finally, acquisitions. As Rich discussed, we purchased TwoFour for about $32 million on an all-cash transaction. This is about a $10 million a year revenue business. We have incorporated TwoFour into our outlook, but the impact will not be material to the results for this year. Neutral on a non-GAAP EPS basis and about $0.01 dilutive on a GAAP basis. Our outlook does not include any assumptions about the impacts of the pending acquisition of the trade processing business of M&T Bank Corporation’s Wilmington Trust Retirement and Institutional Services unit. We'll update you on any impacts on the earnings call following the close of the transaction. Now focusing on Slide 8 and starting at the top. Recurring fee revenue grew 7% as Net New Business once again contributed the majority or 4 points of that growth. Internal growth added another 2 points with mutual funds interim positions growth of 8%, while stock record positions grew 7%. Also, equity trades were up 9% in the quarter. Finally, rounding out the recurring fee growth, the Emerald acquisition, which will anniversary in February, contributed another point of growth. Moving to the bottom of the page. Total revenues grew 10% with half of that coming from recurring fee growth. Low margin distribution revenues were up 16% reflecting higher event-driven activity versus the prior year. Recognizing that the second half contributes more revenue than the first half, our Q2 year-to-date recurring fee and total revenue growth of 6% is right in line with our full year guidance of 5% to 7% recurring fee growth and 4% to 6% total revenue growth despite the drag from FX. The Q2 and Q2 year-to-date EBIT margin of 10% was in line with our expectation and puts us on track to achieve our full year margin target of 17.4% to 17.8% with the seasonally higher second-half margins to come. Once again, we had abnormally high sales, general and administrative expense growth of 18%, reflecting increased levels of investment in the business including sales capabilities. As well, we had a higher performance based compensation expenses, which are a result in part of the sales commissions associated with the 111% closed recurring sales growth in the quarter. Again, the high SG&A growth rates for Q2 and year-to-date are not representative of the expected full year growth rate for this line item. Now turning to Slide 9 and the performance of the segments. ICS posted another quarter of double-digit recurring fee growth, 13%, with contributions from both solid Net New Business performance from our emerging and acquired products and healthy positions growth. Event-driven revenue was up versus the prior year, driven by equity proxy specials, around beneficial equity and mutual fund proxy activity. Additionally, the Emerald acquisition, which does not anniversary until February, accounted for 3 points of the 13% growth. As a reminder from Investor Day, we have formally renamed our Securities Processing Solutions or SPS segment Global Technology and Operations or GTO. GTO revenues grew 2%. We continued to post strong recurring closed sales in GTO and strong revenue growth from new sales. As we had expected, a few losses in fiscal year 2014, primarily as a result of platform rationalization, are dampening revenue growth a bit. We also saw strong internal trade growth in equities of 9%, which is offset by lower support activity. Let's move on to Slide 10. This is a slide we have not included in the past and represents a summary of the key metrics that Rich and I use to discuss and measure performance. We think this format can be helpful in communicating our current outlook succinctly and more efficiently than we did previously across several slides. To orient you, the column on the left here shows the outlook we provided at our last call in November and then our current outlook on the right. Again, we are reaffirming full year guidance and have updated 2 metrics. As I noted earlier, we now expect our tax rate to come in closer to 34.5% for the full year given discrete tax benefit I mentioned earlier. Given the strong performance year-to-date in the ICS segment, we have increased the high-end of the ICS revenue growth range by a percentage point to 8%. All else holds. As a reminder, our outlook includes the very modest impacts from the TwoFour acquisition. We do not include acquisitions that have not yet closed, including the pending acquisition of the trade processing business of M&T Bank Corporation’s Wilmington Trust Retirement and Institutional Services unit. In closing, we remain committed to the growth and capital stewardship objectives we outlined at our Investor Day. To reiterate, over the next 3 years through fiscal year 2017 on a compounded annual growth rate basis, we are targeting recurring revenue growth of 7% to 10%, total revenue growth of 5% to 7% and earnings growth of 9% to 11% before taking into account additional interest expense associated with our targeted increase and our leverage ratio. With respect to capital stewardship, we remain committed to targeting a 45% dividend payout ratio on the prior years adjusted net earnings. Further, we are targeting the increase, our debt levels, to about 2:1 debt-to-EBITAR ratio over the next couple of years. In doing this, we anticipate being able to fully fund our tuck-in acquisition plan and increase our level of share repurchases. As always, we will tell you about share repurchases after the fact. The dividend and share repurchases should yield about 3 to 4 points of total shareholder return through fiscal year 2017. One last note before I hand the call back to Rich. We repurchased approximately 220,000 shares for about $10 million in Q2 using proceeds from the exercise of stock options. Rich?